BioHealth News Archive
Maximize Your Impact: Sponsorship Opportunities at the 10th Annual BioHealth Capital Region Forum
As we gear up for the 10th Annual BioHealth Capital Region Forum on September 17th-18th, 2024, at the US Pharmacopeia in Rockville, MD, we…
Read More
TEDCO Invests in Phycin, Inc.
Maryland-based company seeks to revolutionize green algae growth factors COLUMBIA, Md., (July 11, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent…
Read More
Finalists selected for inaugural Bio Centrifuge Africa Competition – BHI’s Rich Bendis to be a Judge
As the first of its kind in South Africa, through a partnership between Eduvos and Task and supported by Wesgro, the inaugural Bio Centrifuge Africa competition will be selecting the winners…
Read More
TEDCO Announces Graham Dodge as the New Vice President, Innovation Connectors
COLUMBIA, Md., (July 11, 2024) — TEDCO, Maryland’s economic engine for technology companies, announces the appointment of Graham Dodge as the vice president of…
Read More
Activation Capital’s President and CEO Announces Departure
RICHMOND, Va., July 8, 2024 – Activation Capital, an innovation ecosystem development organization, announced today that Chandra Briggman, president and chief executive officer of Activation…
Read More
Axios – How AI is driving the venture capital market
Artificial intelligence is keeping the venture capital ecosystem afloat. It accounted for more than 40% of new private U.S. "unicorns" in the first half this year,…
Read More
Emergent, J&J settle COVID vaccine supply deal dispute
July 8 (Reuters) - Emergent BioSolutions (EBS.N), opens new tab said on Monday Johnson & Johnson (JNJ.N), opens new tab has agreed to pay $50 million to settle…
Read More
Elevate Your Startup: Apply to Compete in the 9th Annual Crab Trap Competition
Are you ready to showcase your company to some of the top minds in the industry? The 9th Annual Crab Trap competition, a highlight…
Read More
Arlington’s Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions
ARLINGTON, Va.--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection,…
Read More
Ascentage Pharma Received US$100 Million Option Payment from Takeda
ROCKVILLE, Md. and SUZHOU, China, July 3, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies…
Read More
Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics
HONG KONG and GERMANTOWN, Md. and SUZHOU, China, July 8, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical…
Read More
Maryland Awards $500K to Early Charm Ventures for Biomanufacturing Incubator at Harford County Facility
BEL AIR, Md., (July 1, 2024) – Maryland Department of Commerce has awarded $500K to Baltimore-based Early Charm to develop a biomanufacturing incubator at a…
Read More
Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic…
Read More
EDA: Biden-Harris Administration Announces Next Funding Round of $504 Million for 12 Tech Hubs Across America
WASHINGTON, DC — The Biden-Harris Administration, through the U.S. Department of Commerce’s Economic Development Administration (EDA), announced another funding round of approximately $504 million in implementation…
Read More
Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for…
Read More